Skip to main content
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
19.99
+0.12 (0.60%)
At close: Mar 28, 2025, 4:00 PM
19.86
-0.13 (-0.65%)
After-hours: Mar 28, 2025, 4:54 PM EDT

Dianthus Therapeutics Revenue

In the year 2024, Dianthus Therapeutics had annual revenue of $6.24M with 120.63% growth. Dianthus Therapeutics had revenue of $1.33M in the quarter ending December 31, 2024, with 190.15% growth.

Revenue (ttm)
$6.24M
Revenue Growth
+120.63%
P/S Ratio
106.81
Revenue / Employee
$79,936
Employees
78
Market Cap
642.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.24M3.41M120.63%
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

DNTH News

More News